Emory Winship Cancer Center

Atlanta, Georgia 30322

0 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Non Muscle Invasive Bladder Cancer, Refractory Multiple Myeloma, Relapse Multiple Myeloma, Urologic Cancer, Urothelial Carcinoma

Studies at this site

• A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling
• MMRC Horizon One: RRMM (MMRC-099) — Running, not enrolling